Announcement on Convening Performance Briefing for 2025 and Q1 2026
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Convening Performance Briefing for 2025 and Q1 2026
Filed with SSE · · 3 pages · Chinese
Release
Shanghai Yizhong Pharmaceutical Co. Ltd. on 6ix
Earlier from Shanghai Yizhong Pharmaceutical
- Announcement on Resolutions of the 16th Meeting of the 2nd Board of Directors
- Announcement on Renewing Engagement of Accounting Firm
- Indicative Announcement on Changes in Shareholder Equity Reaching Integer Multiple of 1%
- Announcement on Initial Sales of the Company's Shares through Call Auction
- Announcement on Preliminary Earnings Estimate for 2025
Later from Shanghai Yizhong Pharmaceutical
- Announcement on Election of Employee Director
- Announcement on Progress in Sale of Repurchased Shares
- Announcement on Result of Shareholding Reduction by Shareholders
- Announcement on Voluntary Disclosure on the Acceptance of the Clinical Trial Application for the Investigational New Drug YXC-002
- Announcement on Early Termination of Current Plan for Sale of Repurchased Shares and Results of the Share Sale
Follow Shanghai Yizhong Pharmaceutical into a list and get an email when it puts out news.
Follow Shanghai Yizhong Pharmaceutical